Issue 44, 2013

RNA binding and inhibition of primer extension by a Ru(iii)/Pt(ii) metal complex

Abstract

AH197, a trinuclear Ru(III)/Pt(II) metal complex, is strikingly more effective than the hallmark anticancer drug cisplatin and the Ru(III) clinical candidate NAMI-A in its binding to RNA and inhibition of primer DNA synthesis. Heteromultinuclear complexes could potentially serve as far better chemotherapeutics than mononuclear complexes.

Graphical abstract: RNA binding and inhibition of primer extension by a Ru(iii)/Pt(ii) metal complex

Supplementary files

Article information

Article type
Communication
Submitted
27 Jan 2013
Accepted
15 Apr 2013
First published
17 Apr 2013

Chem. Commun., 2013,49, 5031-5033

RNA binding and inhibition of primer extension by a Ru(III)/Pt(II) metal complex

S. S. Jain, C. M. Anderson, F. DiRienzo, I. R. Taylor, K. Jain, S. Guha and N. Hoque, Chem. Commun., 2013, 49, 5031 DOI: 10.1039/C3CC40699G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements